ESHRE Guideline on Female Fertility Preservation is now available

24 September 2020

The guideline aims to help providers meet a growing demand for FP options by diverse groups of patients, including those diagnosed with cancer or benign diseases undergoing gonadotoxic treatments, transgender men, and women requesting oocyte cryopreservation for age-related fertility loss. The guideline makes 78 recommendations on information provision and support, pre-FP assessment, FP intervention and after treatment care.

Help us improve our understanding of SARS-CoV-2 infection in fertility treatment

17 September 2020

The ESHRE COVID-19 working group has prepared a case reporting tool to improve the understanding of the impact of COVID-19 on pregnancies and ART.
Data collected comprises information on the infection, the fertility treatment and pregnancy, and neonatal and obstetric outcomes.
If you have treated patients with COVID-19 in your practice, please fill in the questionnaire.

Need or no need for septum incision: that´s the question!

15 September 2020

Register now for the upcoming webinar during which the ESHRE Special Interest Group Reproductive Surgery will review physiopathology, diagnosis and reproductive outcome of septate uterus, associated pathology and the pros and cons of surgical resection with some tips for consideration during the procedure.

PCOS is linked to increased risk of neuropsychiatric disorders in offspring

01 September 2020

Human Reproduction Press Release
Children born to mothers with polycystic ovary syndrome (PCOS) are at greater risk of a wide range of psychiatric and neurodevelopmental disorders, according to new research published in Human Reproduction, one of the world’s leading reproductive medicine journals.